A citation-based method for searching scientific literature

. Diabetes Care 2012
Times Cited: 1680







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
5

Global estimates of the prevalence of diabetes for 2010 and 2030.
J E Shaw, R A Sicree, P Z Zimmet. Diabetes Res Clin Pract 2010
5

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.
David R Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw. Diabetes Res Clin Pract 2011
4

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V Chobanian, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright,[...]. JAMA 2003
4

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
4

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.
Aram V Chobanian, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright,[...]. Hypertension 2003
4

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.
Solomon Tesfaye, Andrew J M Boulton, Peter J Dyck, Roy Freeman, Michael Horowitz, Peter Kempler, Giuseppe Lauria, Rayaz A Malik, Vincenza Spallone, Aaron Vinik,[...]. Diabetes Care 2010
3

Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.
Vincenza Spallone, Dan Ziegler, Roy Freeman, Luciano Bernardi, Simona Frontoni, Rodica Pop-Busui, Martin Stevens, Peter Kempler, Jannik Hilsted, Solomon Tesfaye,[...]. Diabetes Metab Res Rev 2011
365
3

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, Richard F Hamman, John M Lachin, Elizabeth A Walker, David M Nathan. N Engl J Med 2002
3

Management of Diabetes in Long-term Care and Skilled Nursing Facilities: A Position Statement of the American Diabetes Association.
Medha N Munshi, Hermes Florez, Elbert S Huang, Rita R Kalyani, Maria Mupanomunda, Naushira Pandya, Carrie S Swift, Tracey H Taveira, Linda B Haas. Diabetes Care 2016
77
3

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
3

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Scott M Grundy, James I Cleeman, C Noel Bairey Merz, H Bryan Brewer, Luther T Clark, Donald B Hunninghake, Richard C Pasternak, Sidney C Smith, Neil J Stone. Circulation 2004
3


The global burden of diabetes and its complications: an emerging pandemic.
Susan van Dieren, Joline W J Beulens, Yvonne T van der Schouw, Diederick E Grobbee, Bruce Neal. Eur J Cardiovasc Prev Rehabil 2010
393
3

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
3



How do we define cure of diabetes?
John B Buse, Sonia Caprio, William T Cefalu, Antonio Ceriello, Stefano Del Prato, Silvio E Inzucchi, Sue McLaughlin, Gordon L Phillips, R Paul Robertson, Francesco Rubino,[...]. Diabetes Care 2009
531
3

Diabetes, oxidative stress, and antioxidants: a review.
A C Maritim, R A Sanders, J B Watkins. J Biochem Mol Toxicol 2003
3

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul K Whelton, Robert M Carey, Wilbert S Aronow, Donald E Casey, Karen J Collins, Cheryl Dennison Himmelfarb, Sondra M DePalma, Samuel Gidding, Kenneth A Jamerson, Daniel W Jones,[...]. J Am Coll Cardiol 2018
3


Social support, quality of life, and self-care behaviors amongAfrican Americans with type 2 diabetes.
Tricia S Tang, Morton B Brown, Martha M Funnell, Robert M Anderson. Diabetes Educ 2008
151
2

Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
Rodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, Vera Bril, Roy Freeman, Rayaz A Malik, Jay M Sosenko, Dan Ziegler. Diabetes Care 2017
481
2

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis.
Raelene E Maser, Braxton D Mitchell, Aaron I Vinik, Roy Freeman. Diabetes Care 2003
344
2

Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Rodica Pop-Busui, Phillip A Low, Barbara H Waberski, Catherine L Martin, James W Albers, Eva L Feldman, Catherine Sommer, Patricia A Cleary, John M Lachin, William H Herman. Circulation 2009
164
2

Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
Marcelo F Di Carli, James Janisse, George Grunberger, Joel Ager. J Am Coll Cardiol 2003
232
2

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.
A D Pradhan, J E Manson, N Rifai, J E Buring, P M Ridker. JAMA 2001
2


Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review.
Saee Hamine, Emily Gerth-Guyette, Dunia Faulx, Beverly B Green, Amy Sarah Ginsburg. J Med Internet Res 2015
366
2


Differences in the management of type 1 diabetes among adults under excellent control compared with those under poor control in the T1D Exchange Clinic Registry.
Jill H Simmons, Vincent Chen, Kellee M Miller, Janet B McGill, Richard M Bergenstal, Robin S Goland, David M Harlan, Joseph F Largay, Elaine M Massaro, Roy W Beck. Diabetes Care 2013
62
3

Does literacy mediate the relationship between education and health outcomes? A study of a low-income population with diabetes.
Dean Schillinger, Lauren R Barton, Andrew J Karter, Frances Wang, Nancy Adler. Public Health Rep 2006
148
2

The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading.
Roy W Beck, Crystal G Connor, Deborah M Mullen, David M Wesley, Richard M Bergenstal. Diabetes Care 2017
120
2


The Oregon experiment--effects of Medicaid on clinical outcomes.
Katherine Baicker, Sarah L Taubman, Heidi L Allen, Mira Bernstein, Jonathan H Gruber, Joseph P Newhouse, Eric C Schneider, Bill J Wright, Alan M Zaslavsky, Amy N Finkelstein. N Engl J Med 2013
477
2






Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
2

SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Remo H M Furtado,[...]. Lancet 2019
753
2


2011 Compendium of Physical Activities: a second update of codes and MET values.
Barbara E Ainsworth, William L Haskell, Stephen D Herrmann, Nathanael Meckes, David R Bassett, Catrine Tudor-Locke, Jennifer L Greer, Jesse Vezina, Melicia C Whitt-Glover, Arthur S Leon. Med Sci Sports Exerc 2011
2


Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Iciar Martín-Timón, Cristina Sevillano-Collantes, Amparo Segura-Galindo, Francisco Javier Del Cañizo-Gómez. World J Diabetes 2014
247
2

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.
Mark A Creager, Thomas F Lüscher, Francesco Cosentino, Joshua A Beckman. Circulation 2003
760
2

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.
Barbora Vozarova, Norbert Stefan, Robert S Lindsay, Aramesh Saremi, Richard E Pratley, Clifton Bogardus, P Antonio Tataranni. Diabetes 2002
415
2


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.